Nocion Therapeuticsincis A Clinical Stage Biopharmaceutical Company Located In Walthammassachusettsfounded In 2017The Company Is Dedicated To Developing Innovative Therapies For Conditions Caused By Neurogenic Inflammationspecifically Targeting Issues Like Coughitchand Painnocion Is Working On A New Class Of Therapies Known Asnocions Which Are Small Molecule Sodium Channel Blockers Designed To Provide Targeted Relief The Company S Lead Producttaplucainium Dry Powder For Inhalationis Currently Being Evaluated In A Phase 2B Study For Patients With Chronic Coughnocion Therapeutics Has Established Strong Partnershipsincluding An Exclusive License To Foundational Intellectual Property From Harvard University And Boston Childrenae S Hospitalhighlighting Its Commitment To Advancing Research In This Fieldthe Company Has Also Secured Significant Fundingincluding A $62 Million Series B Financing Round In 2024With Backing From Several Prominent Venture Investors
No conferences found for this company.
| Company Name | Nocion Therapeutics Inc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
